ATSA Injection belongs to the group of medicines called anti-metabolites used to treat myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia. ATSA Injection contains Azacitidine, a nucleoside metabolic inhibitor which works by preventing cancer cells from growing. It incorporates into the genetic material of the cells and interferes with the production of new DNA and RNA. This helps correct problems with the maturation and growth of young blood cells in the bone marrow, which causes myelodysplastic disorders.

FAQs

How does ATSA Injection work?

ATSA Injection works by preventing cancer cells from growing. Thereby, it helps treat cancer.

Is it safe to father a child during treatment with ATSA Injection?

Men should avoid fathering a child whilst on treatment with ATSA Injection. Consult the doctor if you wish to conserve your sperm before starting the treatment. Use effective contraception during the treatment with ATSA Injection and for three months after stopping the treatment.

Does ATSA Injection cause differentiation syndrome?

ATSA Injection may cause a serious immune reaction known as differentiation syndrome. Consult the doctor immediately if you experience fever, rash, difficulty breathing, cough, decreased urine, rapid weight gain, low blood pressure, or swelling of the legs or arms.